| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5723838cfc3775d34156e4604ba8d4d7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-9121 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C245-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-34 |
| filingDate |
2005-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03b6b5b291376ec751ef85ac9f297ccf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cf931ca3be3460564dc3d7944e8536a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20cb66aa49adb82395df6c9c9dbf5192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d16cfcf90a9bfcc3226ce2c5d925841a |
| publicationDate |
2007-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-RE39866-E |
| titleOfInvention |
Nonpeptide insulin receptor agonists |
| abstract |
Modulation of the activity of the insulin receptor, enhancement of glucose uptake by cells, and other effects significant in the control and management of diabetes are accomplished using compounds of the formula n n nwhereinn each A is independently a proton-accepting substituent; each R is independently a noninterfering substituent; n is 0, 1, or 2; and each linker is independently an isostere of —NHCONH— or of —N═N— or of —NHCO—. nn Compounds in the genus of Formula (1) can also be used for structure activity studies to identify features responsible for the relevant activities. |
| priorityDate |
1997-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |